Patent ID: 7982033

Claim:
A compound selected from the group consisting of N 2 -(5-cyclopropyl-1H-pyrazol-3-yl)-N 4 -((1S)-1-(4-fluorophenyl)ethyl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine N 2 -(5-cyclopropyl-1H-pyrazol-3-yl)-N 4 -((1S)-1-methylpentyl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine, N 4 -(1-benzyl-3-pyrrolidinyl)-N 2 -(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine, N 4 -(3-cyclopropyl-1H-pyrazol-5-yl)-N 2 -((1S)-1-phenylethyl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine, N 4 -(3-cyclopropyl-1H-pyrazol-5-yl)-N 2 -((1R)-1-phenylethyl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine, N 4 -((1S)-1-(4-fluorophenyl)ethyl)-N 2 -(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine, N 4 -cycloheptyl-N 2 -(5-cyclopropyl-1H-pyrazol-3-yl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine, N 4 -(cyclohexylmethyl)-N 2 -(5-cyclopropyl-1H-pyrazol-3-yl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine, N 4 ((1S)-1-cyclohexylethyl)-N 2 -(5-cyclopropyl-1H-pyrazol-3-yl)pyrrolo[2,1-f][1,2,4]triazine-2,4-diamine, or a pharmaceutically acceptable salt or stereoisomer thereof.